Back to Nuveen, LLC Nuveen, LLC

TXGTXG
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in 10x Genomics Inc Class A

Nuveen, LLC holds 1.1M shares of TXG (10x Genomics Inc Class A), worth $43.1M as of 2026-Q2. The position was increased (+79.7% shares). TXG represents 0.0% of Nuveen, LLC's portfolio.

Current Value

$43.1M

Current Shares

1.1M

Total Value Change

+$41.4M

Total Shares Change

+923,572

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+79.7%
$43.1M0.0%$38.34
45
2026-Q1
Increased
625,796
+164.7%
$13.3M0.0%$22.62
45
2025-Q4
Increased
236,403
+3.5%
$3.9M0.0%$16.29
28
2025-Q3
Unchanged
228,528
0.0%
$2.7M0.0%$11.34
0
2025-Q2
Increased
228,528
+13.7%
$2.6M0.0%$11.73
30
2025-Q1
New
201,061
-
$1.8M0.0%$9.16
36

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used